ACDIS CCDS Dumps Questions Answers

This scenario requires a clinical validation query. The diagnosis of respiratory failure is documented, but the remainder of the record lacks clinical evidence supporting it. CDI should not automatically accept the diagnosis solely because it appears in a progress note, nor should the specialist unilaterally remove or invalidate the provider's diagnosis.

The appropriate process is to present relevant patient-specific clinical information objectively and ask the responsible provider to clarify whether respiratory failure remains clinically appropriate. A compliant validation query should permit the provider to confirm the diagnosis, document another condition, indicate that it was ruled out, or provide another clinically appropriate response.

Looking only for CPAP documentation is inadequate because CPAP can be used for multiple conditions and its presence or absence does not independently determine whether respiratory failure exists. Similarly, simply refusing to code the diagnosis without seeking clarification bypasses the provider's clinical judgment and the organization's validation process.

The 2026 ACDIS/AHIMA query guidance is now the current foundational standard and supersedes earlier versions of the practice brief.

CCDS Reference Topics: Clinical validation; compliant querying; unsupported diagnoses; documentation integrity.

=========

Under the FY 2026 Hospital-Acquired Condition Reduction Program (HACRP), applicable subsection (d) hospitals in the worst-performing quartile based on the Total HAC Score receive a 1% payment reduction on applicable Medicare fee-for-service payments. CMS defines the worst-performing quartile as hospitals whose Total HAC Score is above the 75th percentile.

The FY 2026 program incorporates the CMS Patient Safety and Adverse Events Composite (PSI 90) plus five healthcare-associated infection measures: CLABSI, CAUTI, specified surgical-site infection, MRSA bacteremia, and C. difficile infection.

A single HAC does not automatically trigger the hospital-wide 1% HACRP reduction. Likewise, CMI is not the criterion used to determine HACRP penalties.

It is also important for CCDS candidates to distinguish the HAC Reduction Program from the separate DRA HAC/POA payment provision. CMS explicitly identifies them as distinct programs.

Accurate documentation and coding are important because quality measures rely on reliable clinical data, but CDI activity must remain focused on accurately representing the clinical record rather than manipulating quality metrics.

CCDS Reference Topics: HAC Reduction Program; PSI 90; HAI measures; quality payment; hospital performance.

=========

The laboratory findings demonstrate reduction in all three major peripheral blood-cell lines: hemoglobin 7.8 indicates anemia, WBC 2,700 indicates leukopenia, and platelets 58 indicate thrombocytopenia. Collectively, this pattern is consistent with pancytopenia, making option C the most appropriate documentation clarification.

The National Cancer Institute defines pancytopenia as a lower-than-normal number of red blood cells, white blood cells, and platelets. Importantly, pancytopenia describes the hematologic state; it does not establish its underlying etiology. Myelodysplastic syndrome was only being ruled out in the scenario, so the CDI specialist should not infer it as the definitive cause.

Thrombocytopenia alone would capture only one component of the abnormal CBC and would fail to represent the simultaneous anemia and leukopenia. Myelophthisis implies marrow displacement or infiltration and cannot be inferred from these counts alone. Likewise, aplastic anemia is a specific bone-marrow failure diagnosis requiring provider determination and supporting diagnostic evaluation.

A compliant query can present pancytopenia as a clinically supported choice while allowing the provider to document another explanation.

CCDS Reference Topics: Hematology; clinical indicators; medical terminology; compliant query opportunity.

=========